Ing. Jan Žigmond
Jan is an experienced analyst of our team in the field of health economics and HTA. In addition, he deals with biostatistics and economic analysis. After completing his engineering studies in 2012, he worked as a health economics analyst at CEEOR (part of the international company Kantar Health from 2015 to 2018), where he mainly deals with health economic modeling, health economic data analysis, data analysis from new drug surveillance studies. market and epidemiological investigations. Jan also lectures in the field of biostatistics.